Insulin resistance, which plays a pivotal role in the pathophysiology of T2D, hypertension, dyslipidemia and MetS, is characterized by reduced sensitivity of tissues to insulin, which is evident from the higher insulin concentrations necessary to reach optimal effect [47,48]. This evidence concerns the gene INS and hypertensive disorder.